Saudi Arabia approves Anktiva, an IL-15 immunotherapy, for bladder and lung cancer, marking its first regulatory clearance ...
This January, the U.S. Department of Health and Human  Services’ Substance Abuse and Mental Health Services Administration is ...
Sarepta Therapeutics saw its stock skid 11% after the company announced preliminary unaudited 2025 sales results that missed analyst forecasts for its marketed Elevidys® (delandistrogene ...
A website long associated with neo-Nazi propaganda is now redirecting visitors straight to the Department of Homeland ...